Speaker Profile

Ph.D., CEO, EzBiome

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, microbiome, bioinformatics and molecular ecology. Dr. Hasan is the Chief Executive Officer of EzBiome Inc., USA. He received his Bachelor and Master’s in microbiology, M.B.A in Marketing and Ph.D. in Microbiology and Genomics. In his multidisciplinary research experience, Dr. Hasan contributed on various independent research projects in the field of infectious communicable diseases and led numerous large-scale genomic, metagenomic and microbiome projects that resulted in multiple patents, 80+ peer-reviewed articles, and over 100 abstracts and conference proceedings on microbiome, biomarker discovery, molecular ecology, and infectious diseases. Dr. Hasan taught numerous webinars and workshops on microbiome and bioinformatics and frequently present his research in scientific conferences nationally and internationally. He is an editorial board member of several scientific journals and continue to serve as ad doc reviewer for 18+ scientific journals.

Microbial Profiling Showcase:

EzBiome is a microbiome company which applies precision microbiome discovery platform to shorten the time for discovery and development of microbiota-based therapeutics and companion diagnostics for microbiome-related diseases.

EzBioCloud – An Advanced Microbiome Platform for Discovery of Exciting New Biology and Transformative Therapeutics!
The microbiome plays a critical role in human health and disease and Bioinformatics is the key to uncover cross-disciplinary microbiome data for novel biomarker discovery, product development, disease dynamics, effects of drugs on the microbiome and vice-versa. The presentation will showcase EzBioCloud Precision Microbiome Discovery Platform and demonstrates how it helps shorten the time for discovery and development of therapeutics and companion diagnostics for microbiome-related diseases.

 Session Abstract – PMWC 2022 Silicon Valley

The PMWC 2022 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.